Merck Millipore代理07-1583 EZH2

2025-06-25

货号:07-1583

品牌:Merck Millipore

规格:EA

目录价:¥4164.00

市场价格:¥3539.40

会员价格:¥3331.20

金山科研平台,产品价格货期咨询微信:jinshanbio Description: Anti-EZH2 (Enhancer of Zeste Homologue 2) Antibody, internal | 07-1583 View All» Promotional Text: Special Shipping Offer on Antibodies100% Performance Guaranteed View All» Specificity: Recognizes EZH2, Mr ~100 kDa. View All» Molecular Weight: 85-100 kDa View All» Epitope: a.a. 260-277 View All» Immunogen: Immunogen was a KLH-conjugated synthetic peptide corresponding to a.a. 260-277 (CTPNIDGPNAKSVQREQS) of human EHZ2 (similar to enhancer of zeste (Drosophila) homolog 2). View All» Background Information: Polycomb protein group complexes are responsible for the regulation of hundreds of genes in mammals and insects. These proteins are responsible for the assembly and packaging of chromatin and for the induction of methylation on Histone H3. EZH2 (enhancer of zeste homologue 2), also known as Enx1, is a member of the polycomb group of proteins and is involved in cell cycle regulation. EZH2 represses transcription via trimethylation of histone H3 on Lys27 (H3K27) as indicated by the fact that RNAi-mediated knockdown of EZH2 resulted in a loss of H3K27 trimethylation. The expression of this protein in human tumors is aggressive for hormone refractory prostate cancer. In breast cancer EZH2 expression was increased in malignant tumors and promoted anchorage independent and invasive growth in vitro. EZH2, also known as ENX-1, is ubiquitously expressed during early embryo genesis, and becomes restricted to the central and peripheral nervous systems and sites of fetal hematopoiesis during later development. In the adult, EZH2 is restricted to the spleen, testis and placenta. EZH2 and BMI-1 genes are co expressed in Reed-Sternberg cells of Hodgkin’s disease. Coexpression of BMI-1 and EZH2 is also associated with cycling cells and degree of malignancy in B-cell non-Hogkin’s lymphoma. EZH2 is involved in the progression of prostate cancer, and has been identified as a marker of aggressive breast cancer. Two transcript variants encoding distinct isoforms have been identified for this gene. View All» Species Reactivity:

  • Human

  • Mouse

  • Rat

  • Xenopus

    View All» Species Reactivity Note: Human. Expected to cross-react with mouse, rat, and Xenopus (bullfrog) based on 100% sequence identity. View All» Application Notes: Western Blot Analysis: A 1:1000 dilution of this lot detected EZH2 in HeLa cell lysate (Figure A).ELISAThe antibody has also been shown to work in direct peptide ELISA (data not shown). View All» Control: HeLa cell lysate. View All» Quality Assurance: Routinely evaluated by Western Blot View All» Purification Method: Affinity Purfied View All» Presentation: Affinity purified from serum. Supplied at 0.57 mg/ml in PBS containing 0.05% sodium azide. View All» Storage Conditions: Stable for 1 year at 2-8°C from date of receipt.Handling Recommendations: To maximize recovery, centrifuge briefly prior to removing the cap. Avoid freeze/thawing the product, which can damage IgG and affect product performance. View All» UniProt Number: Q15910 View All» Entrez Gene Number: NM_004456.3 View All» Gene Symbol:
    • EZH2

    • KMT6

      View All» Alternate Names:
      • Enhancer of zeste homolog 2

      • Lysine N-methyltransferase 6

      • enhancer of zeste 2

      • enhancer of zeste homolog 2

      • ENX-1

        View All» Usage Statement: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. View All» Key Applications:
        • Western Blotting

        • ELISA

          View All» Entrez Gene Summary: This gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. This protein may play a role in the hematopoietic and central nervous systems. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq] View All» UniProt Summary: FUNCTION: Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' and 'Lys-27' of histone H3, leading to transcriptional repression of the affected target gene. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1 and CDKN2A. CATALYTIC ACTIVITY: S-adenosyl-L-methionine + histone L-lysine = S-adenosyl-L-homocysteine + histone N6-methyl-L-lysine. SUBUNIT: Binds ATRX via the SET domain (Probable). Component of the PRC2/EED-EZH2 complex, which includes EED, EZH2, SUZ12, RBBP4 and RBBP7 and possibly AEBP2. The minimum components required for methyltransferase activity of the PRC2/EED-EZH2 complex are EED, EZH2 and SUZ12. The PRC2 complex may also interact with DNMT1, DNMT3A, DNMT3B and PHF1 via the EZH2 subunit and with SIRT1 via the SUZ12 subunit. Interacts with HDAC1 and HDAC2. INTERACTION:P26358:DNMT1; NbExp=3; IntAct=EBI-530054, EBI-719459;Q9Y6K1:DNMT3A; NbExp=3; IntAct=EBI-530054, EBI-923653;Q9UBC3:DNMT3B; NbExp=3; IntAct=EBI-530054, EBI-80125;P10276:RARA; NbExp=2; IntAct=EBI-530054, EBI-413374;SUBCELLULAR LOCATION: Nucleus. TISSUE SPECIFICITY: Expressed in many tissues. Overexpressed in numerous tumor types including carcinomas of the breast, colon, larynx, lymphoma and testis. DEVELOPMENTAL STAGE: Expression decreases during senescence of embryonic fibroblasts (HEFs). Expression peaks at the G1/S phase boundary. INDUCTION: Expression is induced by E2F1, E2F2 and E2F3. Expression is reduced in cells subject to numerous types of stress including UV-, IR- and bleomycin-induced DNA damage and by activation of TP53/p53. PTM: Phosphorylated by AKT1. Phosphorylation by AKT1 reduces methyltransferase activity. SIMILARITY: Belongs to the histone-lysine methyltransferase family. EZ subfamily. SIMILARITY: Contains 1 SET domain. CAUTION: Two variants of the PRC2 complex have been described, termed PRC3 and PRC4. Each of the three complexes may include a different complement of EED isoforms, although the precise sequences of the isoforms in each complex have not been determined. The PRC2 and PRC4 complexes may also methylate 'Lys-26' of histone H1 in addition to 'Lys-27' of histone H3 (PubMed:15099518 and PubMed:15684044), although other studies have demonstrated no methylation of 'Lys-26' of histone H1 by PRC2 (PubMed:16431907). View All» Product Name: Anti-EZH2 (Enhancer of Zeste Homologue 2), internal Antibody View All» Antibody Type: Polyclonal Antibody View All» Qty/Pk: 100 µL View All» Format: Purified View All» Host: Rabbit View All»

          © 金山科研平台是专业的授权总代理区域代理经销平台。
          © 如需询价,请加客服QQ:1749072012 、客服微信:jinshanbio,或发送邮件到1749072012@qq.com
          © 平台为生命科学研究相关领域提供一站式耗材试剂仪器解决方案和采购服务,数据资源基于CC协议。
          © 本文地址:https://16ao.com/thread-134984.htm
          © Merck Millipore代理07-1583 EZH2,产品报价联系微信jinshanbio
产品询价需求提交
产品询价请加微信:jinshanbio
返回
扫码添加客服微信,咨询产品报价